Fibreoptic phototherapy for neonatal jaundice
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fibreoptic Phototherapy for Neonatal Jaundice." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431761/all/Fibreoptic_phototherapy_for_neonatal_jaundice.
Fibreoptic phototherapy for neonatal jaundice. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431761/all/Fibreoptic_phototherapy_for_neonatal_jaundice. Accessed January 31, 2025.
Fibreoptic phototherapy for neonatal jaundice. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431761/all/Fibreoptic_phototherapy_for_neonatal_jaundice
Fibreoptic Phototherapy for Neonatal Jaundice [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431761/all/Fibreoptic_phototherapy_for_neonatal_jaundice.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fibreoptic phototherapy for neonatal jaundice
ID - 431761
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431761/all/Fibreoptic_phototherapy_for_neonatal_jaundice
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -